FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Nutriband Inc. Signs Exclusive Manufacturing Agreement with Diomics for its Diocheck Technology”
Nutriband Inc. (NASDAQ: NTRB) surged over 44% in premarket trading after the company signed an exclusive manufacturing agreement with San Diego-based Diomics for its Diocheck technology.
The Diocheck patch is a simple way for individuals to monitor for the presence of antibodies to SARS-CoV-2 during the critical gap between when a person receives a COVID-19 vaccine and when a protective level of antibodies is circulating in the body.
Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse deterrent fentanyl patch incorporating our AVERSA ® technology. Aversa is an abuse deterrent transdermal technology that incorporates aversive agents to prevent the abuse, diversion, misuse and accidental exposure of drugs with abuse potential, specifically opioids.
For more information, please visit: Nutriband Inc.
About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.
The post “The Buzz” Show: Nutriband Inc. (NASDAQ: NTRB) Manufacturing Agreement with Diomics first appeared on Financial Buzz .
For further details see:
“The Buzz” Show: Nutriband Inc. (NASDAQ: NTRB) Manufacturing Agreement with Diomics